[Federal Register Volume 78, Number 92 (Monday, May 13, 2013)]
[Pages 27974-27975]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-11294]



National Institutes of Health

Proposed Collection; 60-Day Comment Request: National Cancer 
Institute (NCI) Alliance for Nanotechnology in Cancer Platform 
Partnership Scientific Progress Reports

SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of 
the Paperwork Reduction Act of 1995, for opportunity for public comment 
on proposed data collection projects, the National Cancer Institute 
(NCI), National Institutes of Health (NIH), will publish periodic 
summaries of proposed projects to be submitted to the Office of 
Management and Budget (OMB) for review and approval.
    Written comments and/or suggestions from the public and affected 
agencies are invited on one or more of the following points: (1) 
Whether the proposed collection of information is necessary for the 
proper performance of the function of the agency, including whether the 
information will have

[[Page 27975]]

practical utility; (2) The accuracy of the agency's estimate of the 
burden of the proposed collection of information, including the 
validity of the methodology and assumptions used; (3) Ways to enhance 
the quality, utility, and clarity of the information to be collected; 
and (4) Ways to minimize the burden of the collection of information on 
those who are to respond, including the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology.
    To Submit Comments and for Further Information: To obtain a copy of 
the data collection plans and instruments, submit comments in writing, 
or request more information on the proposed project, contact: Dorothy 
Farrell, Center for Strategic Scientific Initiatives, Office of Cancer 
Nanotechnology Research, National Cancer Institute, 31 Center Drive, 
Bldg. 31 A, Rm. 10A52, Bethesda, MD 20892 or call non-toll-free number 
301-496-5652 or Email your request, including your address to: 
[email protected]. Formal requests for additional plans and 
instruments must be requested in writing.
    Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 60 days 
of the date of this publication.
    Proposed Collection: National Cancer Institute (NCI) Alliance for 
Nanotechnology in Cancer Platform Partnership Scientific Progress 
Reports, 0925-NEW, National Cancer Institute (NCI), National Institutes 
of Health (NIH).
    Need and Use of Information Collection: National Institutes of 
Health grantees are required to submit interim and final progress 
reports and other post-award documents associated with the monitoring, 
oversight, and closeout of an award. This submission represents a 
request for OMB to approve new program specific progress report 
guidelines for Cancer Nanotechnology Platform Partnerships (CNPP) 
awarded by the National Cancer Institute (NCI). The CNPPs are part of 
the Alliance for Nanotechnology in Cancer, a network of awards funded 
by NCI to promote the application of nanotechnology to cancer research 
and care. The proposed guidelines request information about award 
performance related to trans-Alliance collaboration, scientific 
milestones, progress towards clinical translation and technology 
commercialization, and education and outreach efforts. The report also 
gathers information on leveraged funding, patents and publications. The 
information is gathered every six months. This information is needed to 
monitor the performance of this special program within NCI, funded 
through Requests for Applications (RFA CA-09-013, released May 29, 
2009) using the cooperative agreement mechanism (U01). The information 
will be used to monitor individual award performance and the 
effectiveness of the program as a whole. The respondents are the 
Principal Investigators of the awards, along with their institutional 
business officials. The awards are administered by and the reports 
reviewed by the Office of Cancer Nanotechnology Research (OCNR), part 
of the Center for Strategic Scientific Initiatives within NCI.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The estimated annualized burden 
hours are 72.

                                        Estimated Annualized Burden Hours
                                                                                  Average time
             Type of respondents                 Number of       Frequency of     per response    Annual burden
                                                respondents        response        (in hours)         hours
Principal Investigators.....................              12                2                3               72

    Dated: May 7, 2013.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, NCI, NIH.
[FR Doc. 2013-11294 Filed 5-10-13; 8:45 am]